• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Infect Dis (Lond) . Lombardy, Northern Italy: COVID-19 second wave less severe and deadly than the first? A preliminary investigation

tetano

Editor, Senior Moderator
Infect Dis (Lond)


. 2021 Feb 9;1-6.
doi: 10.1080/23744235.2021.1884745. Online ahead of print.
Lombardy, Northern Italy: COVID-19 second wave less severe and deadly than the first? A preliminary investigation


Andrea Borghesi[SUP] 1 [/SUP], Salvatore Golemi[SUP] 1 [/SUP], Nicola Carapella[SUP] 1 [/SUP], Angelo Zigliani[SUP] 1 [/SUP], Davide Farina[SUP] 1 [/SUP], Roberto Maroldi[SUP] 1 [/SUP]



Affiliations

Abstract

Background: The much-heralded second wave of coronavirus disease (COVID-19) has arrived in Italy. Right now, one of the main questions about COVID-19 is whether the second wave is less severe and deadly than the first wave. In order to answer this challenging question, we decided to evaluate the chest X-ray (CXR) severity of COVID-19 pneumonia, the mechanical ventilation (MV) use, the patient outcome, and certain clinical/laboratory data during the second wave and compare them with those of the first wave.
Methods: During the two COVID-19 waves two independent groups of hospitalised patients were selected. The first group consisted of the first 100 COVID-19 patients admitted to our hospital during the first wave. The second group consisted of another 100 consecutive COVID-19 patients admitted to our hospital during the second wave. We enlisted only Caucasian male patients over the age of fifty for whom the final outcome was available. For each patient, the CXR severity of COVID-19 pneumonia, the MV use, the patient outcome, comorbidities, corticosteroid use, and C-reactive protein (CRP) levels were considered. Nonparametric statistical tests were used to compare the data obtained from the two waves.
Results: The CXR severity of COVID-19 pneumonia, the in-hospital mortality, and CRP levels were significantly higher in the first wave than in the second wave (p ≤ .041). Although not statistically significant, the frequency of MV use was higher in the first wave.
Conclusions: This preliminary investigation seems to confirm that the COVID-19 second wave is less severe and deadly than the first wave.

Keywords: COVID-19; SARS-CoV-2; chest X-ray; mechanical ventilation; scoring system.
 
Back
Top Bottom